SEC
Filings

Menu

Tabs Financials

SEC Filings

Filing date Form Description Filing Group View
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
PRE 14A

A preliminary proxy statement providing notification matters to be brought to a vote

Proxy Filings
View HTML
10-K/A

Amendment to a previously filed 10-K

Annual Filings
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
SC 13G/A

An amendment to the SC 13G filing

Other
View HTML
424B3

Form of prospectus reflecting facts events constituting substantive change from last form

Registration Statements
View HTML

Data provided by Kaleidoscope.

 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe